Avalo Therapeutics
AVTX
AVTX
6 hedge funds and large institutions have $14.2M invested in Avalo Therapeutics in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
-3
Holders Change %
-33.33%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$10.7M |
Top Sellers
| 1 |
Bank of New York Mellon
New York
|
-$14K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$10K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.53K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $13.6M | +$10.7M | +4,381 | +373% |
|
|
NMC
2
NEA Management Company
Timonium,
Maryland
| $506K | – | – | – |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $48K | -$2.53K | -1 | -5% |
|
4
Commonwealth Equity Services
Waltham,
Massachusetts
| $11K | – | – | – |
|
5
BlackRock
New York
| $3K | – | – | – |
|
|
TWA
6
TCI Wealth Advisors
Tucson,
Arizona
| $3K | – | – | – |
|
|
7
Bank of New York Mellon
New York
| – | -$14K | -9 | Closed |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$10K | -6 | Closed |
|